Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Anxiety Over Prospects For Legislative 510(k) Reform Appears To Be Growing

This article was originally published in The Gray Sheet

Executive Summary

FDA and industry are concerned Congress will revise the 510(k) process and defended the program and warned against statutory reforms during a panel discussion at the Food and Drug Law Institute annual meeting in Washington, D.C

You may also be interested in...



510(k) Reform Debate Resurfaces As GAO Completes Mandated Report

The device industry is laying the groundwork to respond to an anticipated government report on the effectiveness of the current 510(k) process

510(k) Reform Debate Resurfaces As GAO Completes Mandated Report

The device industry is laying the groundwork to respond to an anticipated government report on the effectiveness of the current 510(k) process

FDA Device Chief Issues Caution On 510(k)s: Data Requests Could Get Steeper

FDA will demand more comprehensive data from a growing subset of 510(k) submissions, CDRH Director Daniel Schultz suggested at a recent industry meeting

Related Content

UsernamePublicRestriction

Register

MT025933

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel